Search
Combining checkpoint blockade with engineered T cells may lead to longer-lasting results in patients with breast cancer, lung cancer, and other solid tumors.
Cancers linked to HPV are on the rise. But only a little over half of all adolescents in the U.S. got the full series of vaccinations. In this Q&A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its fiscal year 2022 financial results today.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Doctors at MSK Kids, the dedicated pediatric service at Memorial Sloan Kettering Cancer Center (MSK), pioneered many advances for pediatric patients in 2022.
New MSK research developed a deep-learning model designed to aid challenging cancer diagnoses; identified key regulators of infection-clearing immune cells; and shed new light on the mechanical forces exerted by immune cells.
Meet Fiona and Stanley Druckenmiller, whose latest venture supports promising new avenues of research for experts at Memorial Sloan Kettering Cancer Center.
Official running program of Memorial Sloan Kettering Cancer Center sets new single-year fundraising record with every dollar raised going directly to cancer research.
Learn how a mentoring program at Memorial Sloan Kettering Cancer Center helped two nurses excel in their roles.